Zeolite–polymer composite adsorbs uremic toxins


Scientists in Japan have developed a nanofibre mesh that can adsorb creatinine from blood with the hope that it can eventually be developed into a wearable blood-cleaning device for patients with kidney failure.

It is hoped the mesh can eventually be developed into a wearable blood-cleaning device

Kidney failure causes dangerous concentrations of waste products, such as potassium, urea and creatinine, to build-up in the body. Apart from having a kidney transplant, the next best solution for patients is dialysis. Dialysis, however, is far from ideal. It is time-consuming and relies on access to specialist equipment, clean water, electricity, dialysate, and, usually, a hospital. Often these requirements aren’t accessible in rural parts of developing countries and disaster areas.

Dialysis works according to the principles of diffusion, but Mitsuhiro Ebara and his team at the National Institute of Materials Science in Ibaraki have taken a different approach and developed a material that cleans blood by adsorption.

Zeolites are adsorbent minerals commonly used in water purification technologies. Different zeolites have different pore sizes meaning they can be used to selectively adsorb specific solutes. Ebara’s group trapped a zeolite into a composite mesh by electrospinning it with the biocompatible polymer, poly(ethylene-co-vinylalcohol) (EVOH), to prevent the zeolite from being released into the bloodstream. They then tested the ability of the composite mesh to adsorb creatinine from solution. The team had worried that the properties of EVOH would disable the adsorption properties of the zeolite, but instead they found the adsorption capacity of the mesh was 67% of the free zeolites.

The greatest challenge was precisely controlling the crystallinity of the polymer-zeolite fibers so that they were both insoluble and hydrophilic, says Ebara. ‘The fibers have to be hydrophilic so that the uremic toxin could access the embedded zeolites, but hydrophilic fibers are not stable in water.’

Ebara’s team calculated that a 16g mesh is enough to remove all the creatinine produced in one day by the human body. They are now designing a wrist-watch sized device that can be connected to the shunt that hemodialysis patients generally have inserted under their skin, as a more accessible and cheap alternative to dialysis treatment.

Thomas Gaborski, a biomedical engineer at the Rochester Institute of Technology in the US is impressed by the work: ‘this straightforward approach could eliminate or reduce the need for the many litres of sterile dialysate used in every hemodialysis treatment.’

The team now plans to target the other uremic toxins involved in kidney disease.

References

This paper is free to access. Download it here:

K Namekawa et al, Biomater. Sci., 2014, DOI: 10.1039/c3bm60263j


Related Content

Caged toxin for safer, better bacterial vaccines

3 December 2013 Research

news image

Hybrid nanoparticles can deliver unmodified toxins giving the immune system a better education to resist future infections

Botox

18 July 2013 Podcast | Compounds

news image

Just 50 grams could kill everyone on the planet, but we have it injected into our faces. David Lindsay on Botox

Most Read

Coated nanoparticles show Alzheimer's promise

12 September 2014 News and Analysis

news image

Gold nanoparticles functionalised with amino acid polymer inhibit the growth of amyloid fibres associated with neurodegenerat...

First flexible graphene display paves the way for folding electronics

11 September 2014 News and Analysis

news image

Team behind the bendy e-reader display hope to have a full colour graphene-based smartphone style screen within a year

Most Commented

Computer simulations point to formamide as prebiotic intermediate in ‘Miller’ mixtures

16 September 2014 News and Analysis

news image

Electric field may have provided more than just energy for primordial chemistry

The trouble with boycotts

29 August 2014 Critical Point

news image

Cutting academic ties with a censured state can do more harm than good, says Mark Peplow